… The present indications for infliximab in inflammatory bowel disease are summarized in Table
1. For control of luminal disease, we use one 5-mg/kg iv infusion followed by maintenance …

… inflammatory bowel diseases (IBD), Crohn’s disease (CD), and ulcerative colitis. Twenty
years ago, … cohort studies for the infliximab biosimilar CT-P13 in inflammatory bowel disease. …

… Antibodies to infliximab (ATIs) have been associated with loss of clinical response and lower
serum infliximab (IFX) levels in some studies of patients with inflammatory bowel disease (…

… of infliximab in inflammatory bowel disease (IBD) but the potential toxicity of this new biological
compound has been less studied. Aim: To assess the use of infliximab in … with infliximab …

… of infliximab in patients with inflammatory bowel disease (IBD… infliximab and 666 control
patients not treated with infliximab … (13%) treated with infliximab and 157 occurred in 126 (19%) …

… The objective of this study is to describe the pharmacokinetics of infliximab and to explore …
of infliximab and its interindividual variability in patients treated for inflammatory bowel disease …

… population-based cohorts of inflammatory bowel disease (IBD) patients treated with infliximab
are sparse. The aim of this article is to describe the use of infliximab in a national Danish …

… of infliximab-treated patients with inflammatory bowel disease between 2009 and 2012.
Interventions Trough levels of infliximab … factor antagonists in inflammatory bowel disease. Clin …

… assessed by the inflammatory bowel disease questionnaire (… efficacy of infliximab in treating
fistulizing Crohn’s disease,[19… to infliximab induction and randomly assigned to infliximab 5 …

… is to review the mechanisms of action of infliximab in IBD. … and endothelial cells in inflammatory
bowel diseases. Adv Exp Med Biol … Adhesion molecules in inflammatory bowel disease: …